IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

BML Capital Management, LLC

Q3 2023 Holdings

Filed 2023-10-23 | 26 holdings | $108.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Ishares TR(SGOV)0-3 MNTH TREASRY46436E718$27.2M270,00025.0%
Spdr SER TR(BIL)BLOOMBERG 1-3 MO78468R663$18.4M200,00016.9%
Atea Pharmaceuticals Inc(AVIR)COM04683R106$14.4M4,800,00013.2%
Cyteir Therapeutics IncCOM23284P103$9.2M3,250,0088.5%
Avrobio IncCOM05455M100$6.2M4,001,6275.7%
Adverum Biotechnologies Inc(ADVMCHF)COM00773U108$5.9M3,915,0005.4%
Talaris Therapeutics IncCOM87410C104$5.6M2,000,0005.2%
Eliem Therapeutics Inc(CLYM)COM28658R106$5.1M1,938,2634.7%
Athira Pharma IncCOM04746L104$3.4M1,704,3623.2%
Astrotech Corp(ASTC)COM046484309$2.2M220,4102.0%
Oramed Pharmaceuticals Inc(ORMP)COM NEW68403P203$2.0M781,2921.9%
Arca Biopharma Inc(ABIOEUR)COM00211Y506$1.4M706,9301.3%
Passage BIO IncCOM702712100$1.4M2,058,7671.2%
Forte Biosciences Inc(TOCAEUR)COM34962G109$1.2M1,761,7021.1%
Milestone Pharmaceuticals in(MIST)COM59935V107$844.8K272,5000.8%
Enliven Therapeutics Inc(ELVN)COM29337E102$683.0K50,0000.6%
Retractable Technologies Inc(RVP)COM76129W105$595.0K499,9590.5%
Verrica Pharmaceuticals IncCOM92511W108$582.8K150,0000.5%
Vistagen Therapeutics Inc(VTGN)COM92840H400$524.0K100,0000.5%
Lisata Therapeutics Inc(LSTA)COM128058302$521.8K243,8390.5%
Invesco QQQ TR(QQQ)PutUNIT SER 146090E103$443.9K1080.4%
Nextcure IncCOM65343E108$395.3K306,4650.4%
Neoleukin Therapeutics IncCOM NEW64049K203$389.7K98,6640.4%
Calcimedica Inc(CALC)COM NEW38942Q202$236.1K88,7810.2%
Rain Oncology IncCOM75082Q105$62.8K72,9260.1%
Surrozen IncCOM86889P109$43.7K89,2710.0%